Takeda Pharmaceutical Co., Ltd. (TAK)
16.60
+0.02
(+0.15%)
USD |
NYSE |
May 19, 16:00
16.60
0.00 (0.00%)
After-Hours: 16:24
Takeda Pharmaceutical EPS Diluted (Quarterly) : -0.0496 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sanofi | -- |
| Eli Lilly & Co. | 8.255 |
| AstraZeneca PLC | 0.9849 |
| Johnson & Johnson | 2.141 |
| Novo Nordisk A/S | 1.709 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -154.60M |
| Revenue (Quarterly) | 6.976B |
| Total Expenses (Quarterly) | 7.131B |
| Enterprise Value | 79.28B |
| Gross Profit Margin (Quarterly) | 48.79% |
| Profit Margin (Quarterly) | -2.22% |
| Earnings Yield | 2.44% |
| Operating Earnings Yield | 6.87% |